204 related articles for article (PubMed ID: 32802198)
21. Restored microRNA-519a enhances the radiosensitivity of non-small cell lung cancer via suppressing EphA2.
Gong S; Li Y; Lv L; Men W
Gene Ther; 2022 Nov; 29(10-11):588-600. PubMed ID: 33414521
[TBL] [Abstract][Full Text] [Related]
22. The EGR1/miR-139/NRF2 axis orchestrates radiosensitivity of non-small-cell lung cancer via ferroptosis.
Zhang L; Xu Y; Cheng Z; Zhao J; Wang M; Sun Y; Mi Z; Yuan Z; Wu Z
Cancer Lett; 2024 Jul; 595():217000. PubMed ID: 38821254
[TBL] [Abstract][Full Text] [Related]
23. Gastric Adenocarcinoma Predictive Long Intergenic Non-Coding RNA Promotes Tumor Occurrence and Progression in Non-Small Cell Lung Cancer via Regulation of the miR-661/eEF2K Signaling Pathway.
Gu H; Chen J; Song Y; Shao H
Cell Physiol Biochem; 2018; 51(5):2136-2147. PubMed ID: 30522114
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
Guo D; Wang Y; Ren K; Han X
Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging.
Chen S; Lu S; Yao Y; Chen J; Yang G; Tu L; Zhang Z; Zhang J; Chen L
Aging (Albany NY); 2020 Jul; 12(14):14329-14340. PubMed ID: 32681720
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
27. miR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC.
Yang D; Wang JJ; Li JS; Xu QY
Oncol Res; 2018 May; 26(4):519-528. PubMed ID: 28734041
[TBL] [Abstract][Full Text] [Related]
28. Aberrant Expression of miR-362 Promotes Lung Cancer Metastasis through Downregulation of Sema3A.
Luo D; Zhang Z; Zhang Z; Li JY; Cui J; Shi WP; Dong XW; Yuan L; Lin P; Chen ZN; Bian HJ; Wang ZL
J Immunol Res; 2018; 2018():1687097. PubMed ID: 30155491
[TBL] [Abstract][Full Text] [Related]
29. Circ_0086720 knockdown strengthens the radiosensitivity of non-small cell lung cancer via mediating the miR-375/SPIN1 axis.
Jin Y; Su Z; Sheng H; Li K; Yang B; Li S
Neoplasma; 2021 Jan; 68(1):96-107. PubMed ID: 32940043
[TBL] [Abstract][Full Text] [Related]
30. LDR-Induced miR-30a and miR-30b Target the PAI-1 Pathway to Control Adverse Effects of NSCLC Radiotherapy.
Park G; Son B; Kang J; Lee S; Jeon J; Kim JH; Yi GR; Youn H; Moon C; Nam SY; Youn B
Mol Ther; 2019 Feb; 27(2):342-354. PubMed ID: 30424954
[TBL] [Abstract][Full Text] [Related]
31. MiR-147a mediated by sodium new houttuyfonate could enhance radiosensitivity of non-small cell lung cancer cells via suppressing STAT3.
Dai K; Chen L; Liu J; Ding Y; Gu C; Lu X
Adv Clin Exp Med; 2021 Feb; 30(2):173-181. PubMed ID: 33650331
[TBL] [Abstract][Full Text] [Related]
32. EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells.
Cai T; Zhou J; Zeng Y; Du W; Zhang Y; Liu T; Fu Y; Huang JA; Qian Q; Zhu J; Ling C; Liu Z
J Exp Clin Cancer Res; 2020 May; 39(1):84. PubMed ID: 32393392
[TBL] [Abstract][Full Text] [Related]
33. Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy.
Ling C; Xie Y; Zhao D; Zhu Y; Xiang J; Yang J
Cancer Gene Ther; 2012 Oct; 19(10):697-706. PubMed ID: 22863759
[TBL] [Abstract][Full Text] [Related]
34. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
Cui D; Qian R; Li Y
Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
[TBL] [Abstract][Full Text] [Related]
35. MiR-145 modulates the radiosensitivity of non-small cell lung cancer cells by suppression of TMOD3.
Li H; Zhao S; Chen X; Feng G; Chen Z; Fan S
Carcinogenesis; 2022 Apr; 43(3):288-296. PubMed ID: 34888652
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells.
Yin ZJ; Jin FG; Liu TG; Fu EQ; Xie YH; Sun RL
J Surg Res; 2011 Dec; 171(2):675-83. PubMed ID: 20605584
[TBL] [Abstract][Full Text] [Related]
37. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma.
Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W
Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441
[No Abstract] [Full Text] [Related]
38. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3.
Yue J; Lv D; Wang C; Li L; Zhao Q; Chen H; Xu L
Oncogene; 2018 Aug; 37(31):4300-4312. PubMed ID: 29717264
[TBL] [Abstract][Full Text] [Related]
40. MiR-598 Suppresses Invasion and Migration by Negative Regulation of Derlin-1 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
Yang F; Wei K; Qin Z; Liu W; Shao C; Wang C; Ma L; Xie M; Shu Y; Shen H
Cell Physiol Biochem; 2018; 47(1):245-256. PubMed ID: 29768262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
